Ticker ARDX – Ardelyx Inc – sales, description, marketcap – Tickerday.com

ARDX

Ardelyx Inc

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 480.47M; Volume: 77.74K; AvgVol 3m: 547.26K; Beta: 1.86;

Cost estimate:

P/E: ; EPS: -1.19; EPS growth quarter/prev quarter: 31.10%;

EPS growth this year: 9.30%; EPS growth past 5 years: -53.50%;

EPS ttm: -1.19;

P/S: 61.75; P/B: 3.39; P/Cashflow: 2.50; P/FCF: ;

Sales: 8.31M; Sales growth quarter/prev quarter: 10100.00%; Sales growth past 5 years: -30.10%;

Profitability:

Gross Margin: 91.10%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -43.60%; ROE – return on equity: -65.90%; LT Debt/Equity: 0.25; Total Debt/Equity: 0.34;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 10.10%; Insider Transactions:-4.45%;

Institutional Ownership: 87.40%; Institutional Transactions: 1.33%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *